Amgen Inc (NASDAQ:AMGN)
| 285.50 Delayed Data As of Dec 02 |  -0.44 / -0.15%Today’s Change | 199.31 Today|||52-Week Range 296.67 | +26.91% Year-to-Date |
Latest AMGN News | Press Releases
| FTX Collapse: Lessons for Investors Dec 03 / MotleyFool.com - Paid Partner Content | Why Horizon Therapeutics Stock Is Skyrocketing Today Nov 30 / MotleyFool.com - Paid Partner Content |
| Is Amgen Stock a Buy for Income Investors? Dec 02 / MotleyFool.com - Paid Partner Content | The Most-Sold Guru Stocks of the 3rd Quarter Nov 28 / GuruFocus News - Paid Partner Content |
| 3 Stocks Every Investor Should Add to Their Watchlist This Week Dec 02 / StockNews.com - Paid Partner Content | Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus Nov 28 / Zacks.com - Paid Partner Content |
| Robeco Institutional Asset Management B.V. Buys 4, Sells 1 in 3rd Quarter Dec 01 / GuruFocus News - Paid Partner Content | Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations Nov 24 / Zacks.com - Paid Partner Content |
| Horizon (HZNP) Up on Initial Talks of Buyout by Pharma Giants Nov 30 / Zacks.com - Paid Partner Content | Buy this Medical Sector Pioneer Stock Nov 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 285.94 |
| Today’s open | 282.89 |
| Day’s range | 282.89 - 286.09 |
| Volume | 139,454 |
| Average volume (3 months) | 2,741,902 |
| Market cap | $152.3B |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -16.60% |
| Earnings growth (this year) | +3.41% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +2.94% |
| P/E ratio | 22.9 |
| Price/Sales | 4.96 |
| Price/Book | 23.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +1.14 | +1.30% |
| ---- | ||
| MRNAModerna Inc | +0.87 | +0.48% |
| BIIBBiogen | -3.03 | -1.00% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $4.10 |
| Annual revenue (last year) | $26.0B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 22.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
